Jonathan Barratt
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy.
Journal: Kidney international
Published: March 14, 2025
The pathogenesis of IgA nephropathy and implications for treatment.
Journal: Nature reviews. Nephrology
Published: July 31, 2024
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis.
Journal: Journal of nephrology
Published: September 19, 2023
Is IgA nephropathy the same disease in different parts of the world?
Journal: Seminars in immunopathology
Published: July 16, 2021
SGLT-2 inhibition in IgA nephropathy: the new standard of care?
Journal: Kidney international
Published: March 25, 2021
Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes.
Journal: Primary care diabetes
Published: January 17, 2020
Treatment of IgA Nephropathy: Evolution Over Half a Century.
Journal: Seminars in nephrology
Published: September 05, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026